Xi'an Faithful BioTech Co., Ltd. yog muag PRL-8-53 Raw Powder. Thov koj xav tiv tauj peb yog tias koj muaj kev xav tau kev yuav khoom.
Xa koj Cov Lus Nug kom paub meej ntxiv, Nyem email:sales4@faithfulbio.com
I. Cov yam ntxwv tseem ceeb ntawm PRL-8-53
(I) Chemical Structure thiab Synthesis Process
PRL-8-53 belongs rau chav kawm phenylethylamine hloov pauv, nrog cov tshuaj formula C₁₁H₁₅NO₂ thiab tus txheeb ze molecular hnyav ntawm 193.24. Qhov kev tsim qauv no tsis yog tsuas yog txhim kho cov khoom sib xyaw ntawm lipid solubility, ua rau nws ua tau zoo hla cov ntshav-hlwb teeb meem thiab ua ncaj qha rau hauv nruab nrab lub paj hlwb, tab sis kuj ntxiv dag zog rau nws cov metabolic stability nyob rau hauv vivo, nteg lub hauv paus rau nws lub sij hawm ntev kev txawj ntse tswj cov teebmeem. Nws yog tsim nyog sau cia tias benzene nplhaib qauv ntawm PRL-8-53 qhia qee qhov zoo sib xws nrog cov qauv ntawm cov neurotransmitter dopamine, uas yog ib qho tseem ceeb ntawm cov txheej txheem ua ntej rau nws txoj kev koom tes hauv kev tswj hwm hauv nruab nrab neurotransmitter. Muab piv rau cov tshuaj lom neeg muab rho tawm los ntawm nootropic, chemically synthesized PRL-8-53 muaj qhov zoo xws li cov txiaj ntsig tswj tau, ruaj khov purity, thiab cov nqi qis qis, muab cov khoom lav rau nws cov kev tshawb fawb dav dav.
(II) Physicochemical Properties thiab Storage Requirements
PRL-8-53 yog xim dawb mus rau dawb crystalline hmoov, tsis muaj ntxhiab tsw, nrog me ntsis iab saj. Cov tshuaj no muaj cov lipid solubility zoo tab sis solubility tsawg hauv dej (kwv yees li 5 mg / mL ntawm 25 degree). Cov cuab yeej physicochemical no tso cai rau nws hla cov ntshav-hlwb teeb meem sai sai thiab ncav cuag qhov muaj txiaj ntsig zoo hauv lub hauv paus paj hlwb. PRL-8-53 muaj qhov melting point ntawm 78-82 degree. Nws ruaj khov ntawm chav tsev kub thiab tsis yooj yim oxidize los yog deteriorate, tab sis tej zaum yuav undergo amide bond hydrolysis nyob rau hauv muaj zog acid los yog alkaline tej yam kev mob, ua rau ib tug txo nyob rau hauv efficiency. Nws cov tshuaj aqueous yog nruab nrab rau tsis muaj zog alkaline, nrog pH ntau ntawm 6.5-7.5, thiab nws qhov kev ruaj ntseg yog qhov zoo nyob rau hauv nruab nrab tej yam kev mob.
Raws li nws cov khoom siv physicochemical, cov ntsiab lus hauv qab no yuav tsum tau hais txog qhov chaw cia ntawm PRL-8-53: Nws yuav tsum muab khaws cia rau hauv qhov chaw kaw, qhuav, thiab zoo{10}} qhov cua qhov chaw, tsis txhob ya raws thiab kub. Qhov ntsuas kub tau pom zoo yog 0-10 degree. Cov tshuaj no yog me ntsis rhiab heev rau lub teeb; Ntev ntev raug rau lub teeb muaj zog tuaj yeem ua rau cov txheej txheem degradation. Yog li ntawd, nws yuav tsum tau ntim rau hauv cov xim av reagent fwj los yog nyob rau hauv lub teeb-pov thawj ntim. Rau kev npaj PRL-8-53 cov kev daws teeb meem, nws raug nquahu kom npaj thiab siv tam sim ntawd. Yog tias yuav tsum tau khaws cia rau lub sijhawm luv luv, lawv yuav tsum tau muab cia rau hauv qhov chaw txias txias ntawm 4℃tsis pub dhau 24 teev kom tsis txhob muaj cov khoom siv hydrolysis, uas yuav cuam tshuam rau kev ua tau zoo thiab kev nyab xeeb ntawm kev siv.
Xa koj Cov Lus Nug kom paub meej ntxiv, Nyem email:sales4@faithfulbio.com
II. Mechanism of Action ntawm PRL-8-53
Txawm hais tias cov txheej txheem tshwj xeeb ntawm kev ua ntawm PRL-8-53 tsis tau qhia meej meej, ntau cov kev tshawb fawb preclinical tau pom tias nws cov txheej txheem tseem ceeb ntawm kev ua haujlwm nyob ib puag ncig kev tswj hwm ntawm neurotransmitters hauv nruab nrab lub paj hlwb, txhim kho kev paub txog kev ua haujlwm los ntawm ntau lub hom phiaj sib koom ua ke, tshwj xeeb tshaj yog ua kom pom tseeb hauv kev nco. Tam sim no tau txheeb xyuas cov txheej txheem ntawm kev nqis tes ua feem ntau tsom rau peb qhov tseem ceeb hauv qab no:
(I) Kev tswj ntawm Cholinergic System Function
Lub cholinergic system yog ib qho tseem ceeb hauv lub hauv nruab nrab lub paj hlwb uas koom nrog hauv kev nco thiab kev sib koom ua ke. Acetylcholine, raws li lub hauv paus tseem ceeb neurotransmitter ntawm lub cev, ncaj qha cuam tshuam rau kev kawm thiab kev nco lub peev xwm vim nws cov ntsiab lus thiab cov teeb liab transduction efficiency. Cov kev tshawb fawb tau lees paub tias PRL-8-53 tuaj yeem ua rau muaj kev nce ntxiv ntawm acetylcholine hauv cov synaptic cleft los ntawm inhibiting cov haujlwm ntawm acetylcholinesterase (AChE), yog li txo cov catabolic metabolism ntawm acetylcholine. Piv nrog rau cov tshuaj acetylcholinesterase ib txwm muaj, PRL-8-53 nthuav tawm cov kev xaiv nruab nrab hauv inhibiting acetylcholinesterase, zam kev nce qib ntawm acetylcholine ntau dhau uas tuaj yeem ua rau cholinergic toxicity, yog li muab kev nyab xeeb zoo dua.
Tsis tas li ntawd, PRL-8-53 tuaj yeem txhim kho cov kev qhia theem ntawm acetylcholine receptors nyob rau hauv lub paj hlwb cortex thiab hippocampus, txhim kho cov kev sib txuas ntawm acetylcholine rau receptors thiab ntxiv txhim kho cholinergic teeb liab transduction efficiency. Raws li lub hauv paus ntawm lub hlwb hauv cheeb tsam rau kev nco, txhim kho cholinergic neural muaj nuj nqi nyob rau hauv lub hippocampus ho txhawb kev nco tau thiab sib sau ua ke, uas yog ib tug ntawm cov tseem ceeb mechanisms uas PRL-8-53 sai txhim kho kev nco. Tsiaj thwmsim qhia tau hais tias tom qab PRL-8-53 kev kho mob, acetylcholine cov ntsiab lus nyob rau hauv lub hippocampus ntawm cov qauv tsiaj muaj zog nce, thiab lawv cov kev ua tau zoo nyob rau hauv lub cim xeeb txog kev coj cwj pwm kev ntsuam xyuas tau zoo dua li cov tswj pawg.
(II) Sib npaug Monoamine Neurotransmitter Levels
Monoamine neurotransmitters (xws li dopamine) ua lub luag haujlwm tseem ceeb hauv cov txheej txheem physiological xws li kev paub txog kev paub thiab kev tswj hwm lub siab. Kev tsis sib xws hauv lawv cov qib ncaj qha cuam tshuam rau kev nco ua haujlwm thiab kev paub txog kev ua haujlwm. PRL-8-53 tuaj yeem tswj hwm qhov sib npaug ntawm cov neurotransmitters hauv nruab nrab paj hlwb los ntawm kev tswj hwm cov txheej txheem metabolic ntawm monoamine neurotransmitters. Cov kev tshawb fawb tau pom tias PRL-8-53 tuaj yeem txhim kho kev ua haujlwm ntawm dopaminergic neural txoj hauv kev los ntawm inhibiting kev ua haujlwm ntawm dopamine transporters (DAT), txo cov dopamine reuptake, thiab nce dopamine concentration hauv synaptic cleft, yog li txhim kho lub hlwb kev mloog thiab cov ntaub ntawv ua haujlwm zoo.
Ib txhij, PRL-8-53 muaj kev tswj xyuas me ntsis ntawm cov kab ke serotonergic, ib feem inhibiting ntau dhau ntawm serotonin tso tawm thiab tiv thaiv kev xav cuam tshuam los ntawm qib serotonin ntau dhau. Qhov tseem ceeb, PRL-8-53 txoj cai tswj hwm ntawm monoamine neurotransmitters yog qhov tseem ceeb ntawm koob tshuaj, ua kom sib npaug ntawm ntau qib ntawm cov neurotransmitters nyob rau hauv qhov kev pom zoo ntau npaum li cas yam tsis ua rau muaj kev cuam tshuam loj ntawm cov neurotransmitter. Tsiaj thwmsim tau lees paub tias tom qab PRL-8-53 kev kho mob, dopamine concentration nyob rau hauv cerebral cortex ntawm cov qauv tsiaj nruab nrab nce, qib serotonin tseem nyob rau hauv ib txwm muaj, thiab kev txawj ntse yooj thiab kev nco muaj peev xwm sib sau ua ke tau zoo dua.
(III) Txhim kho Synaptic Plasticity thiab Neural Conduction
Synaptic plasticity yog hais txog kev hloov pauv ntawm cov qauv synaptic thiab kev ua haujlwm, lub hauv paus tseem ceeb rau kev kawm thiab kev nco. Nws qhov kev ua haujlwm poob qis yog ib qho ntawm cov txheej txheem tseem ceeb ntawm cov txheej txheem pathological ua rau kev nco ploj. Cov kev tshawb fawb tau pom tias PRL-8-53 tuaj yeem txhim kho synaptic kis tau tus mob tau zoo los ntawm kev txhawb nqa kev tso tawm ntawm cov neurotransmitters los ntawm presynaptic membrane thiab txhim kho qhov rhiab heev ntawm receptors ntawm postsynaptic membrane. Tsis tas li ntawd, qhov sib xyaw no tuaj yeem txhim kho qib kev qhia ntawm synapse-txog cov proteins hauv lub hlwb (xws li synaptophysin thiab PSD-95), txhawb kev loj hlob thiab ruaj khov ntawm cov qauv synaptic thiab txhim kho synaptic plasticity.
Nyob rau theem ntawm neural conduction, PRL-8-53 tuaj yeem txo qis qis qis ntawm cov paj hlwb ntawm cov paj hlwb, txo lub sijhawm nce ntawm qhov muaj peev xwm ua haujlwm, thiab ua kom cov kev ua haujlwm ceev ntawm cov hlab ntsha impulses, yog li ua kom lub hlwb ua haujlwm hauv kev ua haujlwm thiab kev sib koom ua ke. Cov txheej txheem ntawm kev ua no txawv ntawm txoj hauv kev ntawm kev ua ntawm cov khoom siv kev txawj ntse-txhim kho cov khoom, tso cai rau PRL-8-53 los txhim kho kev txawj ntse yam tsis muaj kev cuam tshuam loj hauv nruab nrab, yog li zam kev tsis zoo xws li insomnia thiab kev ntxhov siab.
III. Kev tshawb fawb thiab kev loj hlob keeb kwm thiab yav tom ntej Prospects ntawm PRL-8-53
Kev tshawb fawb thiab kev loj hlob ntawm PRL-8-53 pib nyob rau hauv 1970s, stemming los ntawm cov kws tshawb fawb xav tau los tshawb nrhiav cov tshuaj nootropic tshiab. Xyoo 1970, Xib Fwb Nikolaus Hansl pab pawg ntawm Creighton University hauv Tebchaws Meskas thawj zaug ua ke PRL-8-53 thiab pom tias qhov sib xyaw no muaj qhov tseem ceeb ntawm kev nco-txhim kho kev ua haujlwm. Xyoo 1975, pab pawg ua tiav qhov kev txheeb xyuas thiab kev tshawb fawb ntawm cov qauv tshuaj ntawm PRL-8-53, lees paub tias nws tuaj yeem txhim kho kev kawm thiab kev nco txog tsiaj txhu yam tsis muaj qhov tseem ceeb hauv lub paj hlwb excitatory lossis inhibitory toxicity.
Hauv xyoo 1978, Hansl pab pawg tau ua thawj zaug tib neeg sim ntawm PRL-8-53, thawj zaug lees paub nws qhov kev nco-txhim kho cov teebmeem thiab kev nyab xeeb rau cov tib neeg noj qab haus huv, ua rau muaj kev xav thoob plaws hauv thaj chaw ntawm nootropics. Nyob rau xyoo 1980, cov kws tshawb fawb tau kawm ntxiv txog cov txheej txheem ntawm kev ua ntawm PRL-8-53, pib qhia meej txog nws cov kev tswj hwm ntawm cov kab mob cholinergic thiab monoamine neurotransmitters.
Nyob rau hauv lub xyoo pua 21st, nrog kev xav tau ntau ntxiv rau kev paub txog kev txawj ntse thiab kev loj hlob sai ntawm cov txheej txheem tshawb fawb neuroscience, PRL-8-53 tau dhau los ua qhov kev tshawb fawb hotspot. Nyob rau hauv xyoo tas los no, cov kws tshawb fawb tau nkag siab ntxiv rau lawv txoj kev nkag siab ntawm nws cov txheej txheem ntawm kev ua los ntawm cov txheej txheem niaj hnub molecular biology, ntxiv rau ntau cov ntaub ntawv tshawb fawb txog kev kho mob thiab lees paub nws txoj kev txhim kho hauv cov qauv kev nco, muab pov thawj tshiab rau nws cov kev siv tshuaj kho mob.
Nyob rau hauv lub neej yav tom ntej, kev tshawb fawb ntawm PRL-8-53 yuav tsom mus rau cov hauv qab no: Ua ntej, nkag siab qhov kev kawm ntawm nws cov txheej txheem ntawm kev ua, siv cov thev naus laus zis xws li gene sequencing thiab lub hlwb duab los qhia meej nws cov hom phiaj tshwj xeeb ntawm qib molecular thiab cellular, muab lub hauv paus theoretical rau kev paub meej meej; Thib ob, ua qhov loj -Tsev soj ntsuam tib neeg los soj ntsuam nws cov txiaj ntsig kev txawj ntse thiab kev nyab xeeb ntev - nyob rau hauv ntau haiv neeg, muab cov ntaub ntawv pov thawj txaus rau kev siv tshuaj kho mob; thiab thib peb, nthuav tawm cov lus qhia tshiab, tshawb xyuas nws cov peev xwm kho mob hauv cov kab mob xws li Alzheimer's kab mob, kev puas siab puas ntsws me me, thiab kev ntxhov siab tom qab, tshwj xeeb tshaj yog nws cov nqi siv hauv kev kho lub cim xeeb.
Tsis tas li ntawd, nrog rau kev txhim kho cov tshuaj kho tus kheej, kev tshawb fawb yav tom ntej yuav tsom mus rau tib neeg caj ces polymorphisms los tshawb txog qhov sib txawv ntawm kev ua tau zoo ntawm PRL-8-53 ntawm cov genotypes sib txawv, muab lub hauv paus rau kev txhim kho cov phiaj xwm kho tus kheej. Ib txhij, cov kev tshawb fawb ntsig txog yuav tsum tau ua tib zoo saib xyuas kev nyab xeeb mus sij hawm ntev ntawm PRL-8-53, tshwj xeeb tshaj yog nws cuam tshuam rau kev ua haujlwm ntev ntawm lub paj hlwb hauv nruab nrab, tso lub hauv paus ruaj ntseg rau nws daim ntawv thov kev kho mob thaum kawg.
Xaus
PRL-8-53, ib qho khoom siv hluavtaws nootropic classic, tuav txoj haujlwm tseem ceeb hauv kev tshawb fawb txog kev paub txog kev txawj ntse vim nws qhov cim xeeb tshwj xeeb- txhim kho cov teebmeem, kev paub txog kev tswj xyuas zoo, thiab kev nyab xeeb zoo. Los ntawm nws qhov kev sib xyaw ua ke thiab kev tshawb fawb ua ntej xyoo 1970 mus rau qhov tsis ntev los no ntawm nws cov txheej txheem thiab kev nthuav dav ntawm cov ntawv thov, cov txiaj ntsig kev tshawb fawb ntawm PRL-8-53 tau tshawb nrhiav tsis tu ncua, muab cov tswv yim tshawb fawb tshiab los daws cov teeb meem ntsig txog kev nco. Nws cov txheej txheem ntawm kev ua, uas txhim kho kev nco los ntawm kev tswj hwm qhov sib npaug ntawm cov kab ke cholinergic thiab monoamine neurotransmitters, tsis tsuas yog muab cov ntsiab lus tseem ceeb rau kev txhim kho cov tshuaj nootropic tab sis tseem ua rau peb nkag siab tob txog cov txheej txheem ntawm kev paub txog kev ua haujlwm.
Txawm hais tias PRL-8-53 tseem nyob rau theem kev tshawb fawb tshawb fawb thiab tseem tsis tau nkag mus rau hauv daim ntawv thov kev kho mob, cov ntaub ntawv tshawb fawb uas twb muaj lawm tau lees paub nws qhov muaj peev xwm kho mob. Kev tshawb fawb yav tom ntej yuav tsum tau ua kom zoo dua cov ntaub ntawv soj ntsuam, qhia meej txog nws qhov kev siv tau thiab kev nyab xeeb mus sij hawm ntev hauv cov neeg sib txawv, txhim kho kev noj tshuaj thiab kev tswj hwm kev noj qab haus huv, thiab ua kom txoj kev tshawb fawb tob txog nws cov txheej txheem ntawm kev ua kom muaj kev txhawb nqa kev tshawb fawb rau nws cov kev kho mob txhais lus. Nws ntseeg tau tias nrog kev nce qib ntawm kev tshawb fawb tsis tu ncua, PRL-8-53 yuav tsum ua lub luag haujlwm tseem ceeb hauv thaj chaw xws li kev paub txog kev paub thiab kev cuam tshuam rau kev nco poob, muab cov kev xaiv tshiab los txhim kho kev paub txog kev noj qab haus huv ntawm cov pejxeem.
Raws li tus neeg muab kev pabcuam hwm PRL-8-53 CAS 51352-87-5, Xi'an Faithful BioTech Co., Ltd. leverages lub xeev-of-the-art technology ntau lawm thiab nruj zoo soj ntsuam kom tau raws li cov kev cai thoob ntiaj teb kws tshuaj. Peb txoj kev mob siab rau kev ua tau zoo tshaj plaws, tus nqi tsim nyog, thiab kev txhawb nqa kev tsim kho tau ua rau peb nyiam koom tes rau cov kws kho mob thiab cov kws tshawb fawb thoob ntiaj teb. Txhawm rau kom tau txais cov ncauj lus qhia ntxaws ntxaws thiab daim ntawv thov kev taw qhia rau peb PRL-8-53 Powder, hu rau peb pab neeg ua haujlwm ntawmsales4@faithfulbio.comthiab tshawb xyuas seb peb cov khoom tuaj yeem txhim kho koj cov khoom tsim li cas.